The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Open accessAbstract
Significant research and preclinical investment in cancer nanomedicine has produced several products, which have improved cancer care. Nevertheless, there exists a perception that cancer nanomedicine 'has not lived up to its promise' because the number of approved products and their clinical performance are modest. Many of these analyses do not consider the long clinical history and many clinical products developed from iron oxide nanoparticles. Iron oxide nanoparticles have enjoyed clinical use for about nine decades demonstrating safety, and considerable clinical utility and versatility. FDA-approved applications of iron oxide nanoparticles include cancer diagnosis, cancer hyperthermia therapy, and iron deficiency anemia. For cancer nanomedicine, this wealth of clinical experience is invaluable to provide key lessons and highlight pitfalls in the pursuit of nanotechnology-based cancer therapeutics. We review the clinical experience with systemic liposomal drug delivery and parenteral therapy of iron deficiency anemia (IDA) with iron oxide nanoparticles. We note that the clinical success of injectable iron exploits the inherent interaction between nanoparticles and the (innate) immune system, which designers of liposomal drug delivery seek to avoid. Magnetic fluid hyperthermia, a cancer therapy that harnesses magnetic hysteresis heating is approved for treating humans only with iron oxide nanoparticles. Despite its successful demonstration to enhance overall survival in clinical trials, this nanotechnology-based thermal medicine struggles to establish a clinical presence. We review the physical and biological attributes of this approach, and suggest reasons for barriers to its acceptance. Finally, despite the extensive clinical experience with iron oxide nanoparticles new and exciting research points to surprising immune-modulating potential. Recent data demonstrate the interactions between immune cells and iron oxide nanoparticles can induce anti-tumor immune responses. These present new and exciting opportunities to explore additional applications with this venerable technology. Clinical applications of iron oxide nanoparticles present poignant case studies of the opportunities, complexities, and challenges in cancer nanomedicine. They also illustrate the need for revised paradigms and multidisciplinary approaches to develop and translate nanomedicines into clinical cancer care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–242 of 242
Zamboni, W. C., Szebeni, J., Kozlov, S., Lucas, A. T., Piscitelli, J. A., & Dobrovolskaia, M. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.012 · Cited by 64
Engelmann, U. M., Shasha, C., Teeman, E., Slabu, I., & Krishnan, K. M. (2018) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2018.09.041 · Cited by 62
Oei, A. L., Korangath, P. C., Mulka, K. R., Helenius, M., Coulter, J. B., Stewart, J., Velarde, E., Crezee, J., Simons, B. W., Stalpers, L. J. A., et al. (2019) · International Journal of Hyperthermia · doi:10.1080/02656736.2019.1685686 · Cited by 61
Self-citationBiological and Medical Aspects of Electromagnetic Fields
Elson, E. C., Barnes, F. S., Chou, C. K., Greenebaum, B., Weaver, J. C., Chizmadzhev, Y., McCormick, D. L., Woloschak, G. E., Paunesku, T., Anderson, L. E., et al. (2018) · CRC Press eBooks · doi:10.1201/9781315221557 · Cited by 60
Immunosurveillance as a regulator of tissue homeostasis
Senovilla, L., Galluzzi, L., Zitvogel, L., & Kroemer, G. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.06.005 · Cited by 59
Relationship between physico-chemical properties of magnetic fluids and their heating capacity
Salas, G., Veintemillas-Verdaguer, S., & Morales, M. P. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.826824 · Cited by 59
Hong, E., & Dobrovolskaia, M. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.005 · Cited by 59
The Role of the Microbiome in Drug Response
Pryor, R. E., Martínez‐Martínez, D., Quintaneiro, L. M., & Cabreiro, F. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023612 · Cited by 59
MONIEM, K. A., & Bhandari, S. (2007) · Transfusion Alternatives in Transfusion Medicine · doi:10.1111/j.1778-428x.2007.00050.x · Cited by 57
Deng, Z., Jin, J., Wang, Z., Wang, Y., Gao, Q., & Zhao, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s124661 · Cited by 57
Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant
Neto, L. M. M., Zufelato, N., Sousa-Junior, A. A., Trentini, M. M., da Costa, A. C., Bakuzis, A. F., Kipnis, A., & Junqueira‐Kipnis, A. P. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1489192 · Cited by 55
Magnetic nanoparticle hyperthermia: A new frontier in biology and medicine?
Ivkov, R. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.857434 · Cited by 54
Self-citationLahiri, B. B., Ranoo, S., & Philip, J. (2017) · Journal of Physics D Applied Physics · doi:10.1088/1361-6463/aa89de · Cited by 54
Preclinical Evaluation and Clinical Translation of Magnetite-Based Nanomedicines
Nuzhina, J., Shtil, A. A., Prilepskii, A. Y., & Vinogradov, V. V. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101282 · Cited by 54
Hatzfeld‐Charbonnier, A. S., Lasek, A., Castéra, L., Gosset, P., Velu, T. J., Formstecher, P., Mortier, L., & Marchetti, P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0506347 · Cited by 52
Varde, K. N. (1964) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1964.tb04380.x · Cited by 49
Integrating nanomedicine into clinical radiotherapy regimens
DuRoss, A. N., Neufeld, M. J., Rana, S. R., Thomas, C. R., & Sun, C. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.07.002 · Cited by 49
Complement Activation by PEGylated Gold Nanoparticles
Quach, H. Q., Kong, R. L. X., & Kah, J. C. Y. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00793 · Cited by 47
Hedayati, M. A., Thomas, O. C., Abubaker‐Sharif, B., Zhou, H., Cornejo, C. M., Zhang, Y., Wabler, M., Mihalic, J. N., Gruettner, C., Westphal, F., et al. (2012) · Nanomedicine · doi:10.2217/nnm.12.98 · Cited by 46
Self-citationWang, H.-Y., Fu, J. C.-M., Lee, Y., & Lu, P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00475-13 · Cited by 46
Zhao, Z., & Rinaldi, C. (2018) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.8b04071 · Cited by 45
Sneezing and Allergic Dermatitis were Increased in Engineered Nanomaterial Handling Workers
Liao, H.-Y., Chung, Y.-T., Lai, C., Lin, M., & Liou, S.-H. (2014) · Industrial Health · doi:10.2486/indhealth.2013-0100 · Cited by 44
Lessons from immuno-oncology: a new era for cancer nanomedicine?
Jiang, W., Yuan, H., Chan, C. K. F., Roemeling, C. A. V., Yan, Z., Weissman, I. L., & Kim, B. Y. S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.34 · Cited by 44
The two directions of cancer nanomedicine
(2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0597-5 · Cited by 43
Conde‐Leborán, I., Serantes, D., & Baldomir, D. (2014) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2014.10.022 · Cited by 40
Self-citationBaumann, D., Hofmann, D., Nullmeier, S., Panther, P., Dietze, C., Musyanovych, A., Ritz, S., Landfester, K., & Mailänder, V. (2012) · Nanomedicine · doi:10.2217/nnm.12.111 · Cited by 38
Hoopes, P. J., Moodie, K. L., Petryk, A. A., Petryk, J. D., Sechrist, S., Gladstone, D. J., Steinmetz, N. F., Veliz, F. A., Bursey, A. A., Wagner, R. J., et al. (2017) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2256213 · Cited by 38
Self-citationIntravenous iron therapy for anemic cancer patients: a review of recently published clinical studies
Lebrun, F., Klastersky, J. A., Levacq, D., Wissam, Y., & Paesmans, M. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3672-1 · Cited by 34
Iron replacement therapy in cancer-related anemia
Baribeault, D., & Auerbach, M. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110039 · Cited by 33
Giant-spin nonlinear response theory of magnetic nanoparticle hyperthermia: A field dependence study
Carrião, M. S., Aquino, V. R. R., Landi, G. T., Verde, E. L., Sousa, M. H., & Bakuzis, A. F. (2017) · Journal of Applied Physics · doi:10.1063/1.4982357 · Cited by 33
Should Intravenous Iron Be the Standard of Care in Oncology?
Auerbach, M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4609 · Cited by 29
Tebaldi, M. L., Oda, C. M. R., Monteiro, L. O. F., de Barros, A. L. B., Santos, C. J., & Soares, D. C. F. (2018) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2018.04.032 · Cited by 29
Rational design of amphiphile-based drug carriers and sterically stabilized carriers
Barenholz, Y., & Cohen, R. (1995) · Journal of Liposome Research · doi:10.3109/08982109509012690 · Cited by 28
Stimulating antitumor immunity with nanoparticles
Sheen, M. R., Lizotte, P. H., Toraya‐Brown, S., & Fiering, S. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1274 · Cited by 25
Self-citationUses and limitation of different thermometers for measuring heating efficiency of magnetic fluids
Skumiel, A., Hornowski, T., Józefczak, A., Koralewski, M., & Leszczyński, B. (2016) · Applied Thermal Engineering · doi:10.1016/j.applthermaleng.2016.02.063 · Cited by 25
Energy considerations in the magnetic (eddy-current) stimulation of tissues
Nyenhuis, J. A., MOUCHAWAR, G. A., BOURLAND, J. D., et al. (1991) · IEEE Transactions on Magnetics · doi:10.1109/20.101117 · Cited by 22
Benefits of Nanomedicine for Therapeutic Intervention in Malignant Diseases
Sevastre, A.-S., Horescu, C., Baloi, C., Cioc, C. E., Vatu, B. I., Tuţă, C., Artene, Ş.-A., Dănciulescu, M. M., Tudorache, Ş., & Dricu, A. (2019) · Coatings · doi:10.3390/coatings9100628 · Cited by 22
Gafter‐Gvili, A., Steensma, D. P., & Auerbach, M. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0069 · Cited by 19
Song, G. K., Suzuki, O., Santos, C., Lucas, A. T., Wiltshire, T., & Zamboni, W. C. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.05.019 · Cited by 18
Hoopes, P. J., Mazur, C. M., Österberg, B., Song, A., Gladstone, D. J., Steinmetz, N. F., Veliz, F. A., Bursey, A. A., Wagner, R. J., & Fiering, S. (2017) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2256062 · Cited by 18
Self-citationIs there any role of intravenous iron for the treatment of anemia in cancer?
Gemici, C., Yetmen, O., Yaprak, G., Özden, S., Tepetam, H., Özyurt, H., & Mayadağlı, A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2686-2 · Cited by 16
Correlation between physical structure and magnetic anisotropy of a magnetic nanoparticle colloid
Dennis, C. L., Jackson, A., Borchers, J. A., Gruettner, C., & Ivkov, R. (2018) · Nanotechnology · doi:10.1088/1361-6528/aab31d · Cited by 14
Self-citation
Cited by
Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Jayasankar, N., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,062
Magnetic nanoparticles in biomedical applications: A review
Materón, E. M., Miyazaki, C. M., Carr, O., Joshi, N., Picciani, P. H. S., Dalmaschio, C. J., Davis, F., & Shimizu, F. M. (2021) · Applied Surface Science Advances · doi:10.1016/j.apsadv.2021.100163 · Cited by 456
Nanozyme for tumor therapy: Surface modification matters
Tang, G., He, J., Liu, J., Yan, X., & Fan, K. (2021) · Exploration · doi:10.1002/exp.20210005 · Cited by 441
Emerging Trends of Carbon‐Based Quantum Dots: Nanoarchitectonics and Applications
Guan, X., Li, Z., Geng, X., Lei, Z., Karakoti, A., Wu, T., Kumar, P., Yi, J., & Vinu, A. (2023) · Small · doi:10.1002/smll.202207181 · Cited by 305
Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives
Montiel Schneider, M. G., Martín, M. J., Otarola, J., Vakarelska, E., Simeonov, V., Lassalle, V., & Nedyalkova, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010204 · Cited by 302
Metadata
- Authors
- Soetaert, F., Korangath, P., Serantes, D., Fiering, S., & Ivkov, R.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2020
- Volume
- 163-164
- Pages
- 65-83
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W3037095003
- Cited by
- 406
- References
- 242
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.